Cognitive functioning among heart transplant recipients, receiving calcineurin inhibitor-free, everolimus-based immunosuppression since the early postoperative phase

被引:0
|
作者
Burker, B. S. [1 ]
Andersson, S. [1 ]
Gullestad, L. [2 ]
Gude, E. [2 ]
Relbo, A. [2 ]
Grov, I. [2 ]
Malt, U. F. [3 ]
Andreassen, A. [2 ]
Fiane, A. E. [4 ]
Haraldsen, I. R. [1 ]
机构
[1] Oslo Univ Hosp, Rikshosp, Dept Psychosomat Med, N-0450 Oslo, Norway
[2] Oslo Univ Hosp, Rikshosp, Dept Cardiol, N-0450 Oslo, Norway
[3] Oslo Univ Hosp, Rikshosp, Dept Res & Educ, N-0450 Oslo, Norway
[4] Oslo Univ Hosp, Rikshosp, Dept Cardiothorac Surg, N-0450 Oslo, Norway
关键词
D O I
10.1016/j.jpsychores.2015.03.036
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:595 / 596
页数:2
相关论文
共 50 条
  • [41] Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus
    Fuchs, Uwe
    Zittermann, Armin
    Ensminger, Stephan M.
    Schulz, Uwe
    Gummert, Jan F.
    [J]. TRANSPLANT IMMUNOLOGY, 2014, 31 (02) : 87 - 91
  • [42] Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients
    Launay, Manon
    Guitard, Joelle
    Dorent, Richard
    Prevot, Yoann
    Prion, Florent
    Beaumont, Laurence
    Kably, Benjamin
    Lecuyer, Lucien
    Billaud, Eliane M.
    Guillemain, Romain
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 553 - 563
  • [43] Mycophenolate and Sirolimus as Calcineurin Inhibitor-Free Immunosuppression Improves Renal Function Better Than Calcineurin Inhibitor-Reduction in Late Cardiac Transplant Recipients With Chronic Renal Failure
    Groetzner, Jan
    Kaczmarek, Ingo
    Schulz, Uwe
    Stegemann, Emilia
    Kaiser, Kristina
    Wittwer, Thorsten
    Schirmer, Johannes
    Voss, Meinolf
    Strauch, Justus
    Wahlers, Thorsten
    Sohn, Hae-Young
    Wagner, Florian
    Meiser, Bruno
    Reichart, Bruno
    Tenderich, Gero
    Stempfle, Hans-Ulrich
    Mueller-Ehmsen, Jochen
    Schmid, Christof
    Vogeser, Michael
    Koch, Karrl Christian
    Reichenspurner, Hermann
    Daebritz, Sabine
    [J]. TRANSPLANTATION, 2009, 87 (05) : 726 - 733
  • [44] De novo calcineurin-inhibitor-free/sirolimus-based immunosuppression in pediatric heart transplant recipients with renal failure
    Fenton, M. J.
    Burch, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S86 - S86
  • [45] Does a sirolimus-based immunosuppression in calcineurin inhibitor-free regime improve chronic renal failure in cardiac transplant recipients independent from blood pressure?
    Dietrich, MM
    Stypmann, J
    Suwelack, B
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 127A - 127A
  • [46] ACUTE REJECTION FEATURES IN DUAL KIDNEY TRANSPLANT RECIPIENTS FROM ELDERLY DONORS: COMPARISON OF CALCINEURIN INHIBITOR-BASED AND CALCINEURIN INHIBITOR-FREE IMMUNOSUPPRESSIVE PROTOCOLS
    Aiello, F. B.
    Furian, L.
    Marino, S.
    Marchini, F.
    Cardillo, M.
    De Fazio, N.
    Rigotti, P.
    Valente, M.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (04) : 1001 - 1007
  • [47] Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from 6 months after heart transplantation: The randomized MANDELA study
    Barten, Markus J.
    Hirt, Stephan W.
    Garbade, Jens
    Bara, Christoph
    Doesch, Andreas O.
    Knosalla, Christoph
    Grinninger, Carola
    Stypmann, Joerg
    Sieder, Christian
    Lehmkuhl, Hans B.
    Porstner, Martina
    Schulz, Uwe
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (11) : 3006 - 3017
  • [48] Conversion from sirolimus to everolimus in maintenance renal transplant recipients within a calcineurin inhibitor-free regimen: results of a 6-month pilot study
    Kamar, N.
    Jaafar, A.
    Esposito, L.
    Ribes, D.
    Durand, D.
    Di-Giambattista, F.
    Tack, I.
    Rostaing, L.
    [J]. CLINICAL NEPHROLOGY, 2008, 70 (02) : 118 - 125
  • [49] Calcineurin Inhibitor-free Immunosuppression Using Everolimus (Certican) after Heart Transplantation: 2 years' Follow-up from the University Hospital Munster
    Stypmann, J.
    Engelen, M. A.
    Eckernkemper, S.
    Amler, S.
    Gunia, S.
    Sindermann, J. R.
    Rothenburger, M.
    Rukosujew, A.
    Drees, G.
    Welp, H. A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1847 - 1852
  • [50] Calcineurin inhibitor-free immunosuppression with belatacept (LEA29Y) in renal transplant: Phase II 12-month results.
    Larsen, C
    Charpentier, B
    Wekerle, T
    Blancho, G
    Zhou, W
    Levy, E
    Vincenti, F
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 293 - 293